Current Issues in Pharmaceutical Residues in Drinking Water

被引:17
作者
Caban, Magda [1 ]
Bialk-Bielinska, Anna [1 ]
Stepnowski, Piotr [1 ]
Kumirska, Jolanta [1 ]
机构
[1] Univ Gdansk, Fac Chem, Inst Environm & Human Hlth Protect, Dept Environm Anal, Ul Wita Stwosza 63, PL-80308 Gdansk, Poland
关键词
Drinking water; legislation; pharmaceutical residues; risk assessment; trace analysis; HUMAN HEALTH-RISK; ENDOCRINE DISRUPTING COMPOUNDS; ORGANIC PERSISTENT POLLUTANTS; PERSONAL CARE PRODUCTS; IN-GROUND WATER; WASTE-WATER; TRANSFORMATION PRODUCTS; SURFACE WATERS; MASS-SPECTROMETRY; BY-PRODUCTS;
D O I
10.2174/1573411012666151009194401
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The presence of pharmaceuticals in drinking water has been a subject of concern for the last ten years because many of these pollutants are persistent in such aquatic matrices. Latest studies have shown that they can pose a ecotoxicological risk due to their potential long-term negative effects on living organism, even though the relatively low concentrations of these compounds in drinking water (ng/L). For this reason, several researchers have been investigating the roles of various drinking water treatment (DWT) processes in the efficiency of these polar pollutants elimination to decrease their release into the drinking water system. What more, from several years the monitoring programs and advance risk assessment are being carried out in order to gives important information for indicators finding (for future monitoring) and consequential regulations. This study critically reviews available literature on pharmaceutical residues in drinking water, starting from their occurrence, fate and finally toxicology significance. Presented review is also presenting the issue of pharmaceuticals detection and products occurred after drinking water treatment. Moreover, it is also intended to provide an proposition into what future directions might be taken by drinking-water regulators, governments, and water suppliers in their challenging task of enhancing the availability of data on the fate, behavior, and ecotoxicity of pharmaceutical residues in drinking water, in order to be fully aware of the potential risks to humans from exposure to traces of pharmaceuticals via drinking water.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 72 条
[1]   Removal of antibiotics from surface and distilled water in conventional water treatment processes [J].
Adams, C ;
Wang, Y ;
Loftin, K ;
Meyer, M .
JOURNAL OF ENVIRONMENTAL ENGINEERING-ASCE, 2002, 128 (03) :253-260
[2]   Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process using reverse osmosis systems [J].
Al-Rifai, Jawad H. ;
Khabbaz, Hadi ;
Schaefer, Andrea I. .
SEPARATION AND PURIFICATION TECHNOLOGY, 2011, 77 (01) :60-67
[3]   Influence of seasonal climate differences on the pharmaceutical, hormone and personal care product removal efficiency of a drinking water treatment plant [J].
Azzouz, Abdelmonaim ;
Ballesteros, Evaristo .
CHEMOSPHERE, 2013, 93 (09) :2046-2054
[4]   Transformation of acetaminophen by chlorination produces the toxicants 1,4-benzoquinone and N-acetyl-p-benzoquinone imine [J].
Bedner, M ;
Maccrehan, WA .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2006, 40 (02) :516-522
[5]   Is biological treatment a viable alternative for micropollutant removal in drinking water treatment processes? [J].
Benner, Jessica ;
Helbling, Damian E. ;
Kohler, Hans-Peter E. ;
Wittebol, Janneke ;
Kaiser, Elena ;
Prasse, Carsten ;
Ternes, Thomas A. ;
Albers, Christian N. ;
Aamand, Jens ;
Horemans, Benjamin ;
Springael, Dirk ;
Walravens, Eddy ;
Boon, Nico .
WATER RESEARCH, 2013, 47 (16) :5955-5976
[6]   Pharmaceuticals and Endocrine Disrupting Compounds in US Drinking Water [J].
Benotti, Mark J. ;
Trenholm, Rebecca A. ;
Vanderford, Brett J. ;
Holady, Janie C. ;
Stanford, Benjamin D. ;
Snyder, Shane A. .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2009, 43 (03) :597-603
[7]   Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada [J].
Boyd, GR ;
Reemtsma, H ;
Grimm, DA ;
Mitra, S .
SCIENCE OF THE TOTAL ENVIRONMENT, 2003, 311 (1-3) :135-149
[8]   Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment [J].
Broseus, R. ;
Vincent, S. ;
Aboulfadl, K. ;
Daneshvar, A. ;
Sauve, S. ;
Barbeau, B. ;
Prevost, M. .
WATER RESEARCH, 2009, 43 (18) :4707-4717
[9]   Therapeutic dose as the point of departure in assessing potential health hazards from drugs in drinking water and recycled municipal wastewater [J].
Bull, Richard J. ;
Crook, James ;
Whittaker, Margaret ;
Cotruvo, Joseph A. .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2011, 60 (01) :1-19
[10]   Human health risk assessment of carbamazepine in surface waters of North America and Europe [J].
Cunningham, Virginia L. ;
Perino, Christopher ;
D'Aco, Vincent J. ;
Hartmann, Andreas ;
Bechter, Rudolf .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2010, 56 (03) :343-351